Skip to main content
. 2023 Apr 14;14:1155746. doi: 10.3389/fimmu.2023.1155746

Table 2.

Interaction between M2 macrophage and NP.

Study Species Experiment Molecular change Phenotype change
(77, 78) Human, rat In vitro : TNF-α, TGF-β1 and Fasl stimulates NPC In vivo : Acupuncture IDD model NPC: Caspase3/8*, Bcl-2#, CCL3/4*, Grem1#, ERK1/2# M2: TGF-β1/smads* NPC: pyroptotic inhibition and apoptosis inhibition NP: retard inflammation-mediated disc degeneration
(38) Rat In vivo : Acupuncture IDD model M2: IL-1β#, IL-6*、TGF-β*, IL-4*, IL-10* NP: Degeneration M2: Migration
(70) Human In vitro : Coculture M2 with NPC In vivo : three-dimensional murine IVD organ culture model NPC: IL-6#, MMP-13#, ADAMTS-4/5#, COL2*, ACAN* NPC: Proliferation NP: Inflammation inhibition, apoptosis inhibition, and senescence inhibition ECM: Anabolism
(73) Mice In vivo : Acupuncture IDD model M2: CD206*, TGF-β1*, smad2/3* NPC: Proliferation M2: Differentiation
(64) Human, rat In vitro : Coculture M2 with NPC In vivo : Acupuncture IDD model NPC: ACAN*, COL2*, MMP-13#, IL-1β/6/12# NPC: Proliferation ECM: Anabolism M2: Differentiation
(81) Human, rat In vitro : Coculture M2 with NPC NPC: MMP-3/9*, COL2#, ACAN#, ERK*, JNK MAPK* M2a: CHI3L1* CD206* NPC: Degeneration M2a: Infiltration
(79, 80) Human In vitro : High dose TGF-β1 stimulates NPC NPC: COL2#, COL1/3*, TIMP-3*, MMP-13*, ALK1/5*, ANGPTL2*, IL-6*, TNF-α*, Smad1/2/3/5/8* M2: TGF-β1(High dose) * NP: Degeneration
(82) Rat In vitro : IL-10 stimulates NPC In vivo : Acupuncture IDD model NPC: p38 MAPK#, COL2*, ACAN*, SOX-9* NP: retard inflammation-mediated disc degeneration
(83) Rat In vitro : Coculture M with young or old NPC Young NPC: IL-10*, MMP1#, IFN-γ# Old NPC: IL-10*, MMP1*, IFN-γ*
M: NO*
Young NP: Higher cell-mediated immunity activity Old NP: Higher humoral immunity activity

*Activate or upregulate; #Downregulate or inhibit; M1, M1 macrophage; M2, M2 macrophage; M, macrophages of unspecified type; NPC, nucleus pulposus cell; NP, nucleus pulposus (nucleus pulposus cell and ECM).